Cardinal Health initiated with an Outperform at William Blair

William Blair initiated coverage of Cardinal Health (CAH) with an Outperform rating. The firm says the company’s pharmaceutical distribution platform creates a “durable competitive moat” and supports “high-growth specialty upside.” The scale of Cardinal’s distribution capabilities and the breadth of its non-distribution services position the company to capitalize on a favorable demand backdrop, the analyst tells investors in a research note.